Respiratory
- ABPA and aspergillus lung infection, cystic fibrosis patients RHC
- Acute Asthma Management, Children Under 2 years, Emergency Department
- Acute wheeze in children 2 years and older: assessment and management
- Acute wheeze: escalation to intravenous therapy for acute wheeze Integrated Care Pathway (ICP) - for patients ≥ 2 years old
- Audiological investigation in cystic fibrosis patients
- Bronchoalveolar (blind) lavage (PICU)
- Cardio-respiratory investigation & management of adolescents with pectus excavatum
- Distal Intestinal Obstruction Syndrome (DIOS) , adhesional obstruction and severe constipation management in children with cystic fibrosis
- Eradication of Burkholderia Species in Children with Cystic Fibrosis
- Eradication of Haemophilus Influenza in Children with Cystic Fibrosis
- Eradication of Pseudomonas Aeruginosa in Children with Cystic Fibrosis
- Eradication of Staphylococcus Aureus in Children with Cystic Fibrosis
- Inhaler device guide for children aged 5 years to 12 years, Primary Care
- Microbiology classification in cystic fibrosis - recommendations for practice RHC, Paediatrics
- MRSA in paediatric cystic fibrosis patients, eradication and treatment
- N-Acetylcysteine (NAC) for the prevention of aminoglycoside associated ototoxicity in children with cystic fibrosis
- Non-tuberculous mycobacterial pulmonary disease, cystic fibrosis patients RHC
- Omalizumab: difficult asthma advice note
- Oral antibiotics for children with Cystic Fibrosis
- Oxygen: prescription and administration in children
- Paediatric IV to oral antibiotic switch therapy (IVOST) guideline